Shares of Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $15.10 and last traded at $15.10, with a volume of 141 shares trading hands. The stock had previously closed at $15.20.
Analyst Ratings Changes
Separately, StockNews.com downgraded Avanos Medical from a "strong-buy" rating to a "buy" rating in a research note on Sunday, November 3rd.
Check Out Our Latest Stock Analysis on Avanos Medical
Avanos Medical Trading Up 4.2 %
The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The firm has a market cap of $727.96 million, a PE ratio of 46.59 and a beta of 0.99. The stock has a 50-day simple moving average of $17.78 and a two-hundred day simple moving average of $20.90.
Institutional Trading of Avanos Medical
Several large investors have recently modified their holdings of the company. Quarry LP bought a new stake in Avanos Medical during the third quarter valued at about $42,000. KBC Group NV grew its stake in shares of Avanos Medical by 63.0% during the 3rd quarter. KBC Group NV now owns 2,833 shares of the company's stock valued at $68,000 after acquiring an additional 1,095 shares during the period. Canada Pension Plan Investment Board purchased a new stake in Avanos Medical in the 2nd quarter worth approximately $70,000. Intech Investment Management LLC bought a new stake in Avanos Medical during the 3rd quarter worth approximately $207,000. Finally, Atom Investors LP purchased a new position in Avanos Medical during the third quarter valued at approximately $210,000. Institutional investors own 95.17% of the company's stock.
Avanos Medical Company Profile
(
Get Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Read More
Before you consider Avanos Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.
While Avanos Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
